Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010646:Phentolamine / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000187:drug effects; D011667:Pulmonary Veins / Q000187:drug effects; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D014043:Tolazoline / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D006830:Hydralazine; D014043:Tolazoline; D007545:Isoproterenol; D003981:Diazoxide; D010646:Phentolamine